newsfilter
← Latest News
GlobeNewswire·

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BioNexus" or the "Company") (NASDAQ:BGLC), an emerging company in the business of selling chemical raw materials in the Southeast Asia